🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, open-label, dose-escalation and randomized dose opti...
Status
Recruiting
Location
Royal Brisbane & Women's Hospital
Start Date
2023-03-15
Trial ID
NCT05720130
Treatments Being Tested
The goal of this phase 3 clinical trial is to determine the clinical effect...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-03
Trial ID
NCT07751133
The purpose of this study is to evaluate intermittent relugolix + androgen ...
Status
Recruiting
Location
Huntsman Cancer Institute at University of Utah
Start Date
2025-10-27
Trial ID
NCT07216248
The purpose of this study is to find out whether mevrometostat in combinati...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08
Trial ID
NCT07592910
Treatments Being Tested
The purpose of this substudy is to assess the efficacy and safety of ifinat...
Status
Recruiting
Location
UCLA Hematology & Oncology ( Site 0003)
Start Date
2025-07-03
Trial ID
NCT06863272
Treatments Being Tested
The aim of this study is to assess treatment patterns, characteristics, and...
Status
Recruiting
Location
Novartis
Start Date
2026-06-30
Trial ID
NCT07677267
This prospective observational study will evaluate quality of life, functio...
Status
Recruiting
Location
Etlik City Hospital Medical Oncology Department
Start Date
2025-10-22
Trial ID
NCT07181122
Treatments Being Tested
The study is an open label, multi-centre, randomized phase III study. The p...
Status
Recruiting
Location
Region Skåne
Start Date
2021-10-27
Trial ID
NCT04983095
Treatments Being Tested
The goal of this clinical trial is to evaluate the outcomes of a shorter tr...
Status
Recruiting
Location
Noordwest Ziekenhuisgroep
Start Date
2024-02-20
Trial ID
NCT07260435
Treatments Being Tested
The purpose of this study was to assess the efficacy, safety, tolerability,...
Status
Completed
Location
Novartis Investigative Site
Start Date
2023-05-16
Trial ID
NCT05670106
Treatments Being Tested